Use of Ir-192 in intercavitary implants

[lambert@HAL.HAHNEMANN.EDU]

The NRC regulations (10CFR35.400) permit the use of Ir-192 for 
interstital treatment of cancer.  Does this mean that using Ir-192 for 
treatment of bronchial tumors or esophageal tumors is not permitted since 
these are intercavitary implants?  


Kent Lambert
LAMBERT@hal.hahnemann.edu

These are my thoughts.  If they are wrong
I accidentally pressed the send instead of
the delete key.  My employer makes no claim
to endorse my opinions.